Focal Salvage Brachytherapy Study (FocaSaBra)

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2028

Conditions
Prostate Cancer
Interventions
RADIATION

brachytherapy

Radiation: focal low dose rate or high dose rate brachytherapy for the lesion with appropriate margin, defined in magnetic resonance or positron emission tomography All recruited participants will be treated with interstitial brachytherapy for local recurrence of prostate cancer. The low dose rate of brachytherapy is used with a total dose of 145 Gy in the clinical target volume for participants after hypofractionated radiotherapy, a high dose rate brachytherapy as monotherapy or boost with external beam radiotherapy The high dose rate brachytherapy with two fractions of 13 Gy in the clinical target volume with a 3 to 14 days break is used after primary low dose rate brachytherapy or external beam radiotherapy alone.

Trial Locations (1)

61-866

RECRUITING

Greater Poland Cancer Centre / Brachytherapy Department, Poznan

All Listed Sponsors
lead

The Greater Poland Cancer Centre

OTHER